文献速递血液净化与透析

血液透析患者常规临床照护中实施ESAS-r:Renal患者报告结局测量的患者与提供者视角

Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-08-25

本研究在加拿大安大略省8个血液透析中心实施埃德蒙顿症状评估系统修订版:肾脏(ESAS-r:Renal),每4-6周评估一次,持续1年。通过调查、访谈和病历审计发现,常规使用可行(7/8中心平均筛查率>80%),能标准化症状筛查、提高患者和提供者对心理社会症状的意识并赋权患者,但在症状管理、医患沟通和跨学科沟通指标上无显著改善。

要点

  • 常规使用ESAS-r:Renal在血液透析中心可行,7/8中心平均筛查率超过80%。
  • ESAS-r:Renal标准化了症状筛查流程,提高患者和提供者对心理社会症状的意识。
  • ESAS-r:Renal赋权患者主动提出症状问题,但未显著改善症状管理等指标。

核心结论

  • ESAS-r:Renal患者报告结局测量或有助于标准化症状筛查、提高对心理社会症状的意识并赋权患者,而非减轻症状负担。

研究设计与样本

  • 加拿大安大略省8个血液透析中心对患者每4-6周使用ESAS-r:Renal评估一次,持续1年。
  • 追踪筛查和完成率,并进行实施前、后调查及实施中期访谈,实施后12个月进行病历审计。
  • 1459例患者完成ESAS-r:Renal;实施前调查完成率58%(n=718),实施后调查完成率56%(n=569);提供者调查应答率分别为71%(n=514)和54%(n=319)。
  • 9例患者/照护者(来自3个中心)和48例提供者(来自所有中心)参与访谈;共审计1207份病历。

主要发现

  • 8个中心中7个平均筛查率超过80%,提示常规使用ESAS-r:Renal在临床实践中可行。
  • ESAS-r:Renal标准化了不同提供者和中心的症状筛查流程。
  • ESAS-r:Renal提高了患者和提供者对症状(尤其是心理社会症状)的意识。
  • ESAS-r:Renal赋权患者向提供者提出症状问题。
  • 用于评估症状管理、医患沟通和跨学科沟通的指标几乎没有统计学显著改善。

临床怎么用

  • 可在血液透析中心常规实施ESAS-r:Renal以标准化症状筛查。
  • 利用ESAS-r:Renal提高患者和提供者对心理社会症状的意识和患者赋权。
  • 不应期望仅通过实施ESAS-r:Renal即可显著改善症状管理或沟通指标。

局限性

  • 多数据来源对ESAS-r:Renal的价值和效果呈现不一致的画面。
  • 研究未报告症状管理、沟通等指标的具体数值和统计学显著性检验结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The Edmonton Symptom Assessment System Revised: Renal is a patient-reported outcome measure used to assess physical and psychosocial symptom burden in patients treated with maintenance dialysis. Studies of patient-reported outcome measures suggest the need for deeper understanding of how to optimize their implementation and use. This study examines patient and provider perspectives of the implementation process and the influence of the Edmonton Symptom Assessment System Revised: Renal on symptom management, patient-provider communication, and interdisciplinary communication. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Eight in-facility hemodialysis programs in Ontario, Canada, assessed patients using the Edmonton Symptom Assessment System Revised: Renal every 4-6 weeks for 1 year. Screening and completion rates were tracked, and pre- and postimplementation surveys and midimplementation interviews were conducted with patients and providers. A chart audit was conducted 12 months postimplementation. RESULTS: In total, 1459 patients completed the Edmonton Symptom Assessment System Revised: Renal; 58% of eligible patients completed the preimplementation survey (n=718), and 56% of patients who completed the Edmonton Symptom Assessment System Revised: Renal at least once completed the postimplementation survey (n=569). Provider survey response rates were 71% (n=514) and 54% (n=319), respectively. Nine patients/caregivers from three sites and 48 providers from all sites participated in interviews. A total of 1207 charts were audited. Seven of eight sites had mean screening rates over 80%, suggesting that routine use of the Edmonton Symptom Assessment System Revised: Renal in clinical practice is feasible. However, the multiple data sources painted an inconsistent picture of the value and effect of the Edmonton Symptom Assessment System Revised: Renal. The Edmonton Symptom Assessment System Revised: Renal standardized symptom screening processes across providers and sites; improved patient and provider symptom awareness, particularly for psychosocial symptoms; and empowered patients to raise issues with providers. Yet, there was little, if any, statistically significant improvement in the metrics used to assess symptom management, patient-provider communication, and interdisciplinary communication. CONCLUSIONS: The Edmonton Symptom Assessment System Revised: Renal patient-reported outcome measure may be useful to standardize symptom screening, enhance awareness of psychosocial symptoms among patients and providers, and empower patients rather than to reduce symptom burden.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Evans JM, Glazer A, Lum R, et al. Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care: Perspectives of Patients and Providers on ESAS-r:Renal. Clin J Am Soc Nephrol. 2020. PMID: 32843371. doi:10.2215/CJN.01840220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。